Biological Response Modifiers in Rheumatoid Arthritis: Systematic Review and Meta-analysis of Safety

about

Biological Response Modifiers in Rheumatoid Arthritis: Systematic Review and Meta-analysis of Safety

Item

http://www.wikidata.org/entity/Q42654704

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Biological Response Modifiers ...... ew and Meta-analysis of Safety

@en

Biological Response Modifiers ...... ew and Meta-analysis of Safety

@nl

type

Item

label

Biological Response Modifiers ...... ew and Meta-analysis of Safety

@en

Biological Response Modifiers ...... ew and Meta-analysis of Safety

@nl

prefLabel

Biological Response Modifiers ...... ew and Meta-analysis of Safety

@en

Biological Response Modifiers ...... ew and Meta-analysis of Safety

@nl

P1476

Biological Response Modifiers ...... ew and Meta-analysis of Safety

@en

P2093

Bharti N Karelia

http://www.w3.org/2001/XMLSchema#string

Bhavisha N Vegada

http://www.w3.org/2001/XMLSchema#string

Nitishkumar D Tank

http://www.w3.org/2001/XMLSchema#string

P2860

Comparing Effects of Biologic Agents in Treating Patients with Rheumatoid Arthritis: A Multiple Treatment Comparison Regression Analysis

Safety of biologics in rheumatoid arthritis: data from randomized controlled trials and registries.

Number needed to treat (NNT): implication in rheumatology clinical practice.

Tumor necrosis factor alpha drugs in rheumatoid arthritis: systematic review and metaanalysis of efficacy and safety.

Choice of Biologic Therapy for Patients with Rheumatoid Arthritis: The Infection Perspective.

Mortality in established rheumatoid arthritis.

A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview.

Rituximab for the treatment of rheumatoid arthritis: an update.

Biologics-based therapy for the treatment of rheumatoid arthritis.

Assessing the safety of biologic agents in patients with rheumatoid arthritis.

P304

92-105

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/JPP.JPP_155_16

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29081616

http://www.w3.org/2001/XMLSchema#string

P932

5642138

http://www.w3.org/2001/XMLSchema#string